Therapeutic Choices for Ovulatory Dysfunctional Abnormal Uterine Bleeding: A Cross-sectional Study in Chinese Women

Author:

ZHAO Xiaoyue1,Luo Min2,TIAN Qinjie2

Affiliation:

1. Medical Science Research Center, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College

2. Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College

Abstract

Abstract Background Ovulatory dysfunction is the primary cause of abnormal uterine bleeding (AUB); however, data on nationwide therapeutic choices of Chinese women are lacking. The aim of this study was to investigate the therapeutic choices of ovulatory dysfunctional abnormal uterine bleeding (AUB-O) in Chinese women and analyse the factors on the selection results.Methods This was a cross-sectional study involving 3527 patients with AUB-O diagnosed by local doctor between 14 and 55 years old. We used questionnaire compiled according to the Chinese AUB-O treatment guidelines to collect the demographic and therapeutic information. Their therapeutic choices were regarded as generally representative of the nation ’s choices.Results The patients were divided into the juvenile group (14–18 years old, n = 84), the reproductive group (19–39 years old, n = 2962) and the senior group (perimenopausal period: 40–55 years old, n = 481). The results showed that irregular menstruation (37.6% − 46.3%), dysmenorrhea (29.9% − 44.4%), and heavy menstrual bleeding (16.7% − 32.2%) were the main symptoms in Chinese AUB-O patients of different ages. Most of the patients chose to seek help in the Department of General Gynecology (78.6% − 90.7%). Among the therapeutic options, combined oral contraceptives (COCs), such as Yasmin I and Yasmin II, met the treatment expectations with high acceptance among patients (36.6%-52.2%).Conclusions It is important to strengthen the endocrine diagnosis ability of doctors in the Department of General Gynecology. With rational education and clinical applications, COCs are expected to become a more prevalent therapeutic option for AUB-O.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3